Sullivan Timothy Eugene

Average Profitability
1.94%
Insider Buys Quantity
1
Insider Buys Sum
$695,259.87
Insider Sells Quantity
14
Insider Sells Sum
$12.32M

Insider Activity of Sullivan Timothy Eugene

According to the SEC Form 4 filings, Sullivan Timothy Eugene, being in a position of

  1. Chief Financial Officer at Apellis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11534 shares for $458,825,
    over all time since 2019-08-29, has bought 23398 shares for $695,260, and sold 153943 shares for $12.32M.

The largest purchase of all time was on 2019-08-29 and amounted to 23398 shares of Apellis Pharmaceuticals, Inc. for $695,260.

The largest sale of all time was on 2023-06-05 and amounted to 37570 shares of Apellis Pharmaceuticals, Inc. for $3.36M.

Biography of Sullivan Timothy Eugene

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$458,8255100

Comparison of Insiders on Amount of Buys and Sells

2025-01-29SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
546
0.0004%
$29.52$16,120-6.91%
2025-01-22SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
3,088
0.0025%
$30.43$93,954-7.96%
2025-01-17SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
1,730
0.0014%
$29.96$51,828-6.31%
2025-01-13SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
2,170
0.0018%
$28.70$62,284-1.75%
2024-04-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
4,000
0.0033%
$58.66$234,640-41.99%
2024-03-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
6,000
0.0049%
$63.22$379,340-42.78%
2024-02-12SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
1,431
0.0012%
$67.77$96,974-44.47%
2024-01-29SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
906
0.0008%
$64.14$58,109-40.99%
2024-01-22SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
3,551
0.003%
$65.00$230,801-40.57%
2024-01-16SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
2,235
0.0019%
$66.81$149,317-40.87%
2023-11-30SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
14,158
0.0122%
$54.73$774,884-23.52%
2023-07-03SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
6,779
0.006%
$89.97$609,928-46.29%
2023-06-05SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
37,570
0.0329%
$89.55$3.36M-44.67%
2023-06-05SaleApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
69,779
0.0606%
$88.80$6.2M-44.67%
2019-08-29PurchaseApellis Pharmaceuticals, Inc.
APLS
Chief Financial Officer
23,398
0.0367%
$29.71$695,260+1.94%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.